JAINY THOMAS: Open Payments
NPI 1699323519 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$585 in 8 payments from 6 companies in 2025. Trend: 2023 $860 · 2024 $569 · 2025 $585
Food & beverage: $585
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| Regeneron Healthcare Solutions, Inc. | 1 | $121 |
| Ascendis Pharma Endocrinology Inc | 1 | $112 |
| Organon LLC | 1 | $102 |
| Eisai Inc. | 3 | $99 |
| Exelixis Inc. | 1 | $30 |
Products named: IMFINZI, DUPIXENT, Yorvipath, VTAMA, Lenvima, CABOMETYX.
Industry payments across TX — which companies pay providers there.
